Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Free PSA is best marker for prostate cancer:

This article was originally published in Clinica

Executive Summary

Free PSA is a better diagnostic of malignancy in prostate cancer than the alternatives of age-specific PSA testing and PSA density calculation, according to a paper in this month's Urology. In the study, the Beckman Coulter Hybritech free-PSA test was found to be have the same sensitivity (95%) as a PSA density measurement, while also being less expensive because it does not need an ultrasound scan. The age-specific reference method was found to be less sensitive than free PSA, missing between 20% and 60% of cancers in men over 60 years old.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076836

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel